PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Latanoprost with timolol - Glaucoma / ocular hypertension

PAD Profile : Latanoprost with timolol - Glaucoma / ocular hypertension Important

Keywords :
Intra-ocular pressure
Brand Names Include :
Fixapost, Xalacom
Important Information :
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care

Traffic Light Status

Status 1 of 2.

Status :
Blue
Formulations :
  • Eye drops (preservative free)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Blue
Formulations :
  • Eye drops
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date
Patient resource
03 June 2026

Committee Recommendations

Date
Committee Name
Narrative
22 July 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.

Preservative free eye drops:

The Surrey & North West Sussex Area Prescribing Committee recommends latanoprost/timolol preservative free eye drops as the first-line combination prostaglandin/beta-blocker eye drop where a preservative-free formulation is required, for the reduction of intraocular pressure in patients with Glaucoma and they will be considered BLUE (with no information sheet) on the traffic light system and  at least 1 month supply should be supplied at initiation.

NB: Patients switching from separate components to the combination product can be switched by the primary care prescriber without the need to refer into an ophthalmologist for review. Primary care prescribers should be mindful of the strength of the timolol during rationalisation.

Associated BNF Codes

11. Eye
11.06.00. Treatment of glaucoma
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More